Europe's largest commercial event for drug indication expansion, repositioning and reformulation strategies
 |
 
|
Learn, partner, promote
World Drug Repositioning Congress Europe 2013 is Europe’s only commercial conference bringing together buyers and sellers from across the drug development industry who are solely focused on repositioning strategies.
The event is designed for Biotech and Pharma players looking to reposition, retask, repurpose or reformulate successful indications and failed compounds to reinvigorate existing R&D pipelines.
More on exhibiting ›
More on attending ›
The track record
- Over 120 pioneers and opinion leaders attended in 2012
- 69% of attendees were of pharma, biotech or academic origin
- 70% of attendees were C-Level, Executive, Director or Manager level
- 15+ countries represented onsite from across Europe, North America and Asia
- Over 600 onsite 1-2-1 meetings facilitated
Learn and innovate
- 25+ speakers in 2013
- 20+ educational sessions
- 8+ roundtable discussions
- 3 super keynote sessions
- 2 practical workshops
Download the sponsorship brochure to find out more about the different packages on offer >
Pursue and partner
- 800+ partnering meetings in 3 days
- 175+ companies in the Total BioPharma Partnering system
- 1-2-1 Speed Networking sessions
- 2 engaging networking lunches and 1 social evening function
- Co-located with 4th World Orphan Drug Congress
Raise and promote
- Commercial platforms to educate and lead
- 10 exhibition opportunities
- 25+ biotech research posters
- 8hrs+ of dedicated customer face time
- Access to bespoke marketing channels
Let us give you an edge
If you’d like to become an exhibitor sponsor or speaker at next year’s event call Ben Scales on +44 (0) 207 092 1185 or email ben.scales@terrapinn.com
co-located with
